肺耐药相关蛋白表达与非小细胞肺癌血管生成的相关性.doc

肺耐药相关蛋白表达与非小细胞肺癌血管生成的相关性 作者：卫小红，马爱群，邵杰，杨岚，陈明伟，王军辉 【摘要】 目的 探讨肺耐药相关蛋白(LRP)、血管内皮生长因子(VEGF)及微血管密度(MVD)在非小细胞肺癌(NSCLC)中的变化、相互关系及可能的机制。方法 应用免疫组化技术检测56例NSCLC癌组织和27例正常对照肺组织中LRP、VEGF表达及MVD情况。结果 ①LRP阳性表达分布于癌细胞胞浆内，表达率66.1%，显著高于对照肺组织(Plt;0.01)，其显著性与病理类型无关；NSCLC组LRP的表达在不同性别、TNM分期、有无淋巴结转移及两年生存率的比较上均无明显统计学意义(Pgt;0.05)。②与对照组比较，NSCLC组VEGF表达明显升高(Plt;0.01)，其显著性与病理类型无关。NSCLC组VEGF表达与TNM分期、有无淋巴结转移相关(Plt;0.05)。③NSCLC组MVD明显高于对照组(Plt;0.01)，其显著性不受病理类型、病理分级的影响。MVD在Ⅲ+Ⅳ期肺癌中为18.5±5.8，明显高于Ⅰ期的13.8±5.1(Plt;0.05)，有淋巴结转移的高于无淋巴结转移者(Plt;0.05)，两年存活的MVD低于两年死亡的MVD(Plt;0.01)。④NSCLC组VEGF、LRP高表达和MVD增高具有一致性(Plt;0.05)。结论 非小细胞肺癌血管生成与肺耐药相关基因具有一定的相关性。LRP的高表达可能与VEGF上调其基因及VEGF促进肿瘤MVD增加有关。抑制肿瘤新生血管的生成有望降低甚或遏制对非小细胞肺癌化疗的耐药性。 【关键词】 非小细胞肺癌；肺耐药相关蛋白；血管生成；免疫组化 ChinaABSTRACT: Objective To investigate the changes in lung resistance-related protein (LRP) and vascular endothelial growth factor (VEGF) expressions and micro-vessel density (MVD) in non-small cell lung cancer (NSCLC), and to elucidate their possible relationship and mechanism. Methods Immunohistochemistry was used to detect changes in LRP and VEGF expressions, and MVD level in lung tissues of 56 NSCLC cases and 27 normal controls. Results ① LRP expression (66.1%) was concentrated in the cytoplasm of cancer cells, which was significantly higher than that in lung tissues of control group (Plt;0.01); the significance was not related to the pathological type. There was no significant difference in LRP expression among gender, TNM stage, lymph node metastasis, and two-year survival in NSCLC (Pgt;0.05). ② In comparison to the control group, NSCLC group had significantly increased VEGF expression (Plt;0.01), which was not related to the pathological type. VEGF expression in NSCLC group had a significant association with TNM stage and lymph node metastasis (Plt;0.05). ③ The NSCLC group had a significantly higher MVD than the control group (Plt;0.01), which was not affected by the pathological type or degree. MVD value (18.5±5.8) of stage Ⅲ and Ⅳ in NSCLC group was signi